High Sensitivity C-Reactive Protein
Also known as: hs-CRP, High Sensitivity CRP, CRP Test, C-Reactive Protein
Overview
High-sensitivity C-reactive protein (hs-CRP) is a laboratory blood test that measures very low levels of C-reactive protein, a substance produced primarily by the liver in response to inflammation. Unlike standard CRP testing, which is often used to detect more significant inflammation from infection or acute illness, hs-CRP is designed to detect low-grade, chronic systemic inflammation. This has made it especially relevant in discussions of cardiovascular risk, metabolic health, and the broader relationship between inflammation and chronic disease.
In conventional and functional medicine alike, hs-CRP is often viewed as a risk marker rather than a diagnosis. Elevated values do not identify a single disease on their own; instead, they may reflect an inflammatory burden associated with factors such as obesity, smoking, insulin resistance, autoimmune activity, poor sleep, chronic stress, periodontal disease, or recent infection or injury. Research suggests that persistently elevated hs-CRP is associated with increased risk of heart attack, stroke, and other cardiovascular events, even in some people whose cholesterol levels are not markedly abnormal.
Interest in hs-CRP has grown because it helps illuminate the role of inflammation in chronic illness. Studies indicate that atherosclerosis is not simply a matter of cholesterol deposition, but also involves immune activation and vascular inflammation. For this reason, hs-CRP is sometimes interpreted alongside lipid markers, blood pressure, glucose regulation, body composition, and lifestyle factors. In broader root-cause or integrative assessments, it may also be considered in the context of digestive health, environmental exposures, inflammatory dietary patterns, and chronic inflammatory conditions.
At the same time, hs-CRP has important limitations. It is non-specific, meaning it can rise for many reasons and may fluctuate over time. A single high result may reflect a temporary issue such as a viral illness, strenuous exercise, or tissue injury rather than long-term inflammatory risk. Most clinical frameworks therefore emphasize interpreting hs-CRP in context and, when appropriate, repeating the test when a person is well. As with any lab marker, meaningful interpretation depends on the overall clinical picture and discussion with a qualified healthcare professional.
Western Medicine Perspective
Western Medicine Perspective
From a conventional medicine standpoint, hs-CRP is best established as a cardiovascular risk stratification tool. Large epidemiologic studies have found that people with higher hs-CRP levels tend to have a higher likelihood of future cardiovascular events. Professional organizations such as the American Heart Association (AHA) and Centers for Disease Control and Prevention (CDC) have historically described broad risk categories for hs-CRP in cardiovascular assessment, while also noting that it is only one part of a larger risk profile. It is not used as a stand-alone test to diagnose coronary artery disease, autoimmune disease, or infection.
Western medicine generally interprets hs-CRP as a marker of inflammation-related risk, particularly when evaluating individuals with intermediate cardiovascular risk or when clarifying risk that may not be captured fully by traditional lipid testing. Research from major trials, including the JUPITER trial, helped increase attention to hs-CRP by showing that individuals with elevated hs-CRP and otherwise average LDL cholesterol could still have substantial cardiovascular risk. More recently, inflammation-targeting research has further supported the idea that inflammatory pathways contribute meaningfully to atherosclerotic disease.
Clinically, hs-CRP may also be reviewed in the context of obesity, metabolic syndrome, type 2 diabetes, chronic inflammatory disorders, smoking status, sleep disturbance, and sedentary behavior, all of which can influence low-grade inflammation. However, because hs-CRP is non-specific, conventional clinicians typically consider possible confounders such as acute infection, trauma, recent surgery, or flare-ups of inflammatory disease before drawing conclusions. Interpretation is generally more useful when combined with medical history, physical examination, and other laboratory findings such as lipids, hemoglobin A1c, liver markers, and sometimes other inflammatory markers.
A key limitation in the Western view is that hs-CRP may help identify risk but does not by itself reveal the exact source of inflammation. As a result, it is often considered a signal to investigate broader context, not an endpoint. Consultation with a healthcare provider is important for understanding whether an elevated result is clinically meaningful and whether repeat testing or additional evaluation is appropriate.
Eastern & Traditional Perspective
Eastern/Traditional Medicine Perspective
In Traditional Chinese Medicine (TCM) and related East Asian medical systems, there is no exact historical equivalent to hs-CRP as a laboratory construct. However, the concept of chronic low-grade inflammation overlaps with traditional pattern-based ideas such as heat, toxic heat, damp-heat, blood stasis, phlegm accumulation, and qi stagnation. Rather than viewing inflammation as a single measurable entity, TCM generally interprets it through a broader assessment of symptoms, constitution, digestion, emotional state, sleep, circulation, and tongue and pulse patterns. An hs-CRP elevation might therefore be seen not as a diagnosis, but as a modern biomarker that may correspond to underlying imbalance.
Within this framework, cardiovascular and metabolic risk may be associated with patterns involving phlegm-damp retention, constrained liver qi, spleen deficiency, or blood stasis, particularly when there are signs of digestive sluggishness, heaviness, fatigue, irritability, or impaired circulation. Traditional approaches have historically aimed to restore systemic balance rather than target a single marker. Research on integrative medicine suggests that some traditional practices—such as dietary therapy, stress regulation, tai chi, qigong, acupuncture, and selected botanical approaches—may influence inflammatory signaling, though the quality and consistency of evidence vary widely.
In Ayurveda, low-grade inflammation is sometimes discussed in relation to ama (incompletely processed metabolic waste), disturbed agni (digestive/metabolic fire), and doshic imbalance, especially when metabolic dysfunction and circulatory concerns are present. Naturopathic and functional traditions may likewise treat hs-CRP as a broad reflection of terrain: immune activation, gut-related inflammation, stress physiology, environmental burden, and lifestyle patterns. These systems often emphasize individualized interpretation and the interconnection between digestion, metabolism, resilience, and inflammation.
From an evidence perspective, traditional systems offer useful conceptual frameworks for understanding chronic inflammatory states holistically, but hs-CRP itself remains a modern biomedical test. Integrative use of the marker is generally strongest when traditional assessment is paired with appropriate medical evaluation, especially because elevated hs-CRP can occasionally reflect clinically significant conditions that require conventional diagnosis and monitoring.
Evidence & Sources
Supported by multiple clinical trials and systematic reviews
- American Heart Association (AHA)
- Centers for Disease Control and Prevention (CDC)
- Ridker PM et al., New England Journal of Medicine
- Pearson TA et al., Circulation
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- Libby P, Nature
- Ridker PM et al., Circulation
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.